Teveten and Constipation - a phase IV clinical study of FDA data

Summary:

Constipation is reported as a side effect among people who take Teveten (eprosartan mesylate), especially for people who are female, 60+ old, also take Synthroid, and have Crohn's disease.

The phase IV clinical study analyzes which people have Constipation when taking Teveten. It is created by eHealthMe based on reports of 1,466 people who have side effects when taking Teveten from the FDA, and is updated regularly.

What is Teveten?

Teveten has active ingredients of eprosartan mesylate. It is often used in high blood pressure. eHealthMe is studying from 1,482 Teveten users. Check the latest studies of Teveten.

What is Constipation?

Constipation is found to be associated with 3,004 drugs and 4,614 conditions by eHealthMe. Check the latest studies of Constipation.

On Jul, 25, 2026

1,466 people reported to have side effects when taking Teveten.
Among them, 20 people (1.36%) have Constipation.

Among these 20 people:

What is the gender of people who have Constipation when taking Teveten? *

female: 75 %
male: 25 %

What is the age of people who have Constipation when taking Teveten? *

What are other drugs people take besides Teveten? *

What are other side effects people have besides Constipation? *

Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 7 people, 35.00%
Proctalgia (pain in the rectum): 7 people, 35.00%
Flatulence (flatus expelled through the anus): 7 people, 35.00%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 7 people, 35.00%
Faecaloma (hard mass of fecal matter): 7 people, 35.00%
Diarrhea: 7 people, 35.00%
Aggression: 6 people, 30.00%
Speech Impairment (Adult) (inability to speak (adult)): 6 people, 30.00%
Memory Loss: 6 people, 30.00%
Muscle Spasms (muscle contraction): 4 people, 20.00%

What are the existing conditions these people have? *

Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 7 people, 35.00%
Osteoporosis (bones weak and more likely to break): 3 people, 15.00%
Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 10.00%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 1 person, 5.00%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 1 person, 5.00%
Irritable Bowel Syndrome: 1 person, 5.00%
Enlarged Prostate: 1 person, 5.00%
Dyspnea (difficult or laboured breathing): 1 person, 5.00%
Chest Pain: 1 person, 5.00%
Back Pain: 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Teveten and have Constipation?

- Check whether Constipation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Teveten:

Teveten (1,482 reports)

Constipation treatments and more:

Constipation (337,879 reports)

Browse all side effects of Teveten:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Constipation:

Constipation (3,004 drugs)

Browse all the conditions that are associated with Constipation:

Constipation (4,614 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on eprosartan mesylate (the active ingredients of Teveten) and Teveten (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.